Cholesterol - A marker of nutritional status in mild to moderate heart failure

International Journal of Cardiology

Volumn 129, Issue 1, 2008, Pages 65-68

  Araújo, José Paulo ^a   Friões, Fernando ^a   Azevedo, Ana ^a   Lourenço, Patrícia ^a   Rocha Gonçalves, Francisco ^a   Ferreira, António ^a   Bettencourt, Paulo ^a  

^a University of Porto   (Portugal)

Author keywords

Cholesterol; Heart failure; Pre albumin; Prognosis; Undernutrition

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CHOLESTEROL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PREALBUMIN; SPIRONOLACTONE; WARFARIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISEASE SEVERITY; FEMALE; HEART FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHOLESTEROL; FEMALE; HEART FAILURE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PREALBUMIN;

EID: 49349093486     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.05.026     Document Type: Article

References (17)

1. Sacks F.M., Pfeffer M.A., Moyle L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. The cholesterol and recurrent events trial investigators. N Engl J Med 335 (1996) 1001-1009
2. MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Heart protection study collaborative group. Lancet 360 (2002) 7-22
3. Cleland J.G., Swedberg K., and Poole-Wilson P.A. Successes and failures of current treatment of chronic heart failure. Lancet 352 Suppl 1 (1998) SI 19-SI 28
4. Vredevoe D.L., Woo M.A., Doering L.V., Brecht M.L., Hamilton M.A., and Fonarow G.C. Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 82 (1998) 323-328
5. Horwich T.B., Hamilton M.A., Maclellan W.R., and Fonarow G.C. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 8 (2002) 216-224
6. Rauchhaus M., Koloczek V., Hans-Dieter V., et al. Inflammation cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol 76 (2000) 125-133
7. Rauchhaus M., Coats A.J.S., and Anker S.D. The endotoxin-lipoprotein hypothesis. Lancet 356 (2000) 930-933
8. Anker S.D., Ponikowski P., Varney S., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349 (1997) 1050-1053
9. Sreedhara R., Avram M.M., Blanco M., Batish R., Avram M.M., and Mittman N. Pre-albumin is the best nutritional predictor of survival in hemodialysis and peritoneal dialysis. Am J Kidney Dis 28 (1996) 937-942
10. Sergi G., Coin A., Enzi G., et al. Role of visceral proteins in detecting malnutrition in the elderly. Eur J Clin Nut 60 (2006) 203-209
11. Anker S.D., and Coats A.J. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 115 (1999) 836-847
12. Chang H.R., and Bistrian B. The role of cytokines in the catabolic consequences of infection and injury. J Parenter Nutr 22 (1998) 156-166
13. Hasper D., Hummel M., Kleber F.X., Reindl I., and Volk H.D. Systemic inflammation in patients with heart failure. Eur Heart J 19 (1998) 761-765
14. Van Lenten B.J., Fogelman A.M., Haberland M.E., and Edwards P.A. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc Natl Acad Sci U S A 83 (1986) 2704-2708
15. Traccy K.J., Morgello S., Koplin B., et al. Metabolic effects of cachetin/tumor necrosis factor are modified by site of production: cachetin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J Clin Invest 86 (1990) 2014-2024
16. Fraunberger P., Schaefer S., Werdan K., Walli A.K., and Seidel D. Reduction of circulating cholesterol and apolipoprotein level during sepsis. Clin Chem Lab Med 37 (1999) 357-362
17. Haehling S, Doehner W, Anker S. Nutrition, metabolism, and complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res in press, doi:10.1016/j.cardiores.2006.08.018.